This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Irene Pak: Innovator in Peptide Research
Introduction
Irene Pak is a notable inventor based in New Brunswick, NJ (US). She has made significant contributions to the field of peptide research, particularly in relation to the enolase protein. Her work has implications for vaccine development and infection treatment.
Latest Patents
Irene Pak holds 1 patent that focuses on peptides derived from the enolase protein. The invention encompasses nucleic acid sequences that encode these peptides. It also includes a composition, specifically a vaccine, that utilizes these enolase peptides or their variants to generate an immune response. This response is crucial for inducing protective antibody responses and enhancing the activity of human neutrophils against infections.
Career Highlights
Irene Pak is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. Her role there has allowed her to engage in groundbreaking research that contributes to public health. Her innovative work in peptide research is paving the way for new therapeutic approaches.
Collaborations
Irene has collaborated with notable colleagues, including Leslie Cope and Tessie Brown McNeely. These partnerships have fostered a collaborative environment that enhances the research and development of new medical solutions.
Conclusion
Irene Pak's contributions to peptide research and vaccine development highlight her role as an influential inventor in the field. Her innovative work continues to impact the medical community positively.